Immunovant, Inc. (IMVT) vs Rhythm Pharmaceuticals, Inc. (RYTM)
A side-by-side comparison of Immunovant, Inc. and Rhythm Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMVT
Immunovant, Inc.
$31.75HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
RYTM
Rhythm Pharmaceuticals, Inc.
$91.13HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — IMVT vs RYTM
growth of $100 · dividends reinvested · last 7yIMVT +234.2% (+18.8%/yr)RYTM +319.8% (+22.7%/yr)RYTM compounded faster over this window
IMVT RYTM
IMVT vs RYTM: by the numbers
- •IMVT is the larger company ($6.55B vs $6.25B market cap).
- •Both run net losses; RYTM's is the smaller (-85.59% vs -7585.86% net margin).
Metrics side by side
Valuation
| Metric | IMVT | RYTM |
|---|---|---|
| P/S ratio | 923.65 | 26.05 |
| P/B ratio | 8.91 | 60.70 |
Profitability
| Metric | IMVT | RYTM |
|---|---|---|
| Gross margin | 0.00% | 89.00% |
| Operating margin | 0.00% | -101.19% |
| Net margin | -7585.86% | -85.59% |
| ROE | -73.19% | -94.50% |
| ROIC | -76.00% | -63.96% |
Growth (annualized)
| Metric | IMVT | RYTM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 278.53% |
| Total return CAGR (5Y) | 29.93% | 49.95% |
Frequently asked
- How have IMVT and RYTM total returns compared?
- Over the past 5 years, IMVT delivered 29.93% and RYTM delivered 49.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Immunovant ROERhythm Pharmaceuticals ROEImmunovant operating marginRhythm Pharmaceuticals operating marginImmunovant revenue growthRhythm Pharmaceuticals revenue growthImmunovant free cash flowRhythm Pharmaceuticals free cash flow
Immunovant & Rhythm Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.